67 related articles for article (PubMed ID: 12715168)
1. HER2 expression in thyroid tumors.
Mondi MM; Rich R; Ituarte P; Wong M; Bergman S; Clark OH; Perrier ND
Am Surg; 2003 Dec; 69(12):1100-3. PubMed ID: 14700299
[TBL] [Abstract][Full Text] [Related]
2. ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer.
Jin Y; Qiu X; He Z; Wang J; Sa R; Chen L
Front Genet; 2022; 13():966365. PubMed ID: 36437939
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine-Refractory Thyroid Cancer: Molecular Basis of Redifferentiation Therapies, Management, and Novel Therapies.
Aashiq M; Silverman DA; Na'ara S; Takahashi H; Amit M
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31533238
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis.
Vuong HG; Duong UNP; Pham TQ; Tran HM; Oishi N; Mochizuki K; Nakazawa T; Hassell L; Katoh R; Kondo T
World J Surg; 2018 Apr; 42(4):1005-1017. PubMed ID: 28913696
[TBL] [Abstract][Full Text] [Related]
5. Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study.
Marcheselli R; Marcheselli L; Cortesi L; Bari A; Cirilli C; Pozzi S; Ferri P; Napolitano M; Federico M; Sacchi S
J Breast Cancer; 2015 Dec; 18(4):378-85. PubMed ID: 26770245
[TBL] [Abstract][Full Text] [Related]
6. Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.
Zhu X; Zhu YJ; Kim DW; Meltzer P; Cheng SY
Am J Cancer Res; 2014; 4(6):776-88. PubMed ID: 25520867
[TBL] [Abstract][Full Text] [Related]
7. Lack of HER-2 gene amplification and association with pathological and clinical characteristics of differentiated thyroid cancer.
Mdah W; Mzalbat R; Gilbey P; Stein M; Sharabi A; Zidan J
Mol Clin Oncol; 2014 Nov; 2(6):1107-1110. PubMed ID: 25279206
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathways associated with aggressiveness of papillary thyroid cancer.
Benvenga S; Koch CA
Curr Genomics; 2014 Jun; 15(3):162-70. PubMed ID: 24955023
[TBL] [Abstract][Full Text] [Related]
9. Prognostic biomarkers in thyroid cancer.
Soares P; Celestino R; Melo M; Fonseca E; Sobrinho-Simões M
Virchows Arch; 2014 Mar; 464(3):333-46. PubMed ID: 24487783
[TBL] [Abstract][Full Text] [Related]
10. EGF and TGF-β1 Effects on Thyroid Function.
Mincione G; Di Marcantonio MC; Tarantelli C; D'Inzeo S; Nicolussi A; Nardi F; Donini CF; Coppa A
J Thyroid Res; 2011; 2011():431718. PubMed ID: 21760980
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of oncoprotein expressions in thyroid papillary carcinoma.
Balta AZ; Filiz AI; Kurt Y; Sucullu I; Yucel E; Akin ML
Med Oncol; 2012 Jun; 29(2):734-41. PubMed ID: 21547408
[TBL] [Abstract][Full Text] [Related]
12. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma.
Zou M; Al-Baradie RS; Al-Hindi H; Farid NR; Shi Y
Br J Cancer; 2005 Nov; 93(11):1277-84. PubMed ID: 16265347
[TBL] [Abstract][Full Text] [Related]
13. Her2/neu overexpression in differentiated thyroid carcinomas predicts metastatic disease.
Kremser R; Obrist P; Spizzo G; Erler H; Kendler D; Kemmler G; Mikuz G; Ensinger C
Virchows Arch; 2003 Apr; 442(4):322-8. PubMed ID: 12715168
[TBL] [Abstract][Full Text] [Related]
14. Her2/neu expression in poorly-differentiated and anaplastic thyroid carcinomas.
Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
Anticancer Res; 2003; 23(3B):2349-53. PubMed ID: 12894514
[TBL] [Abstract][Full Text] [Related]
15. Her2/neu expression in C-cell hyperplasia and medullary thyroid carcinomas.
Ensinger C; Prommegger R; Kendler D; Gabriel M; Spizzo G; Mikuz G; Kremser R
Anticancer Res; 2003; 23(3B):2241-3. PubMed ID: 12894498
[TBL] [Abstract][Full Text] [Related]
16. HER2 Analysis in Sporadic Thyroid Cancer of Follicular Cell Origin.
Ruggeri RM; Campennì A; Giuffrè G; Giovanella L; Siracusa M; Simone A; Branca G; Scarfì R; Trimarchi F; Ieni A; Tuccari G
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929428
[TBL] [Abstract][Full Text] [Related]
17. Thyroid cancers. I. Papillary, follicular, and Hürthle cell.
Goldman ND; Coniglio JU; Falk SA
Otolaryngol Clin North Am; 1996 Aug; 29(4):593-609. PubMed ID: 8844732
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
